Clinical trials market is evidencing a significant growth in emerging economies. India, especially is illustrating significant growth rate due to its large patient base with diverse gene pool that allows the Pharma companies and CROs to conduct clinical trials in more effective method. The average cost savings in conducting clinical trials in BRIC economies extends from 20% to 60%. However, increased interaction and review of ethical committees and training would provide cohesive environment that can further boost the market for clinical trials in developing economies.
Browse market data tables and in-depth TOC on Clinical Trials Market in (Brazil, Russia, India, China) BRIC (2010 - 2015)
Early buyers will receive 10% customization of reports.
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
7557 Rambler Road,
Suite 727, Dallas, TX 75231